27 Apr 2020 Bionest Actions Around Drug Pricing Centering on Insulin An increasing number of diabetes patients face affordability challenges for their insulin. How are pharma companies and the government responding?
13 Apr 2020 Bionest FDA Finalizes Gene Therapy Guidelines and Adds New Draft Guidance on Orphan Drug Exclusivity The field of gene and cell therapy is flourishing. How is the FDA responding?